85.58
price down icon0.37%   -0.41
 
loading
Merck Co Inc stock is traded at $85.58, with a volume of 3.82M. It is down -0.37% in the last 24 hours and up +3.46% over the past month. Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$85.99
Open:
$85.655
24h Volume:
3.82M
Relative Volume:
0.32
Market Cap:
$213.80B
Revenue:
$63.43B
Net Income/Loss:
$16.42B
P/E Ratio:
13.19
EPS:
6.4861
Net Cash Flow:
$14.72B
1W Performance:
-3.52%
1M Performance:
+3.46%
6M Performance:
+8.20%
1Y Performance:
-21.92%
1-Day Range:
Value
$85.37
$86.46
1-Week Range:
Value
$85.37
$88.94
52-Week Range:
Value
$73.31
$111.58

Merck Co Inc Stock (MRK) Company Profile

Name
Name
Merck Co Inc
Name
Phone
908-740-4000
Name
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Name
Employee
75,000
Name
Twitter
@Merck
Name
Next Earnings Date
2025-02-04
Name
Latest SEC Filings
Name
MRK's Discussions on Twitter

Compare MRK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
MRK
Merck Co Inc
85.59 214.78B 63.43B 16.42B 14.72B 6.4861
Drug Manufacturers - General icon
LLY
Lilly Eli Co
822.17 747.19B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
190.39 459.32B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
231.78 407.19B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
129.72 251.72B 53.40B 13.68B 16.89B 6.8864

Merck Co Inc Stock (MRK) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-17-25 Downgrade Berenberg Buy → Hold
May-14-25 Downgrade Citigroup Buy → Neutral
Apr-22-25 Initiated Cantor Fitzgerald Neutral
Feb-18-25 Downgrade Deutsche Bank Buy → Hold
Feb-10-25 Downgrade TD Cowen Buy → Hold
Jan-08-25 Downgrade Truist Buy → Hold
Dec-20-24 Downgrade BMO Capital Markets Outperform → Market Perform
Dec-10-24 Resumed BofA Securities Buy
Dec-04-24 Upgrade HSBC Securities Hold → Buy
Nov-15-24 Initiated Wolfe Research Peer Perform
Nov-11-24 Downgrade Daiwa Securities Buy → Neutral
Oct-17-24 Initiated Bernstein Mkt Perform
Mar-11-24 Downgrade Societe Generale Hold → Sell
Jan-04-24 Upgrade TD Cowen Market Perform → Outperform
Nov-09-23 Initiated Deutsche Bank Buy
Oct-27-23 Upgrade BMO Capital Markets Market Perform → Outperform
Oct-20-23 Upgrade UBS Neutral → Buy
Jul-14-23 Initiated HSBC Securities Hold
Apr-13-23 Upgrade Citigroup Neutral → Buy
Mar-28-23 Downgrade Societe Generale Buy → Hold
Mar-13-23 Downgrade Wells Fargo Overweight → Equal Weight
Mar-06-23 Initiated Jefferies Buy
Feb-22-23 Upgrade Wolfe Research Peer Perform → Outperform
Jan-04-23 Upgrade BofA Securities Neutral → Buy
Nov-18-22 Initiated Credit Suisse Outperform
Oct-10-22 Upgrade Guggenheim Neutral → Buy
Sep-14-22 Upgrade Berenberg Hold → Buy
Jul-06-22 Upgrade Daiwa Securities Neutral → Buy
Jun-06-22 Resumed SVB Leerink Outperform
Apr-06-22 Resumed Morgan Stanley Equal-Weight
Dec-17-21 Initiated Goldman Buy
Dec-16-21 Initiated Daiwa Securities Neutral
Dec-13-21 Downgrade UBS Buy → Neutral
Dec-09-21 Initiated Wells Fargo Overweight
Dec-07-21 Downgrade Guggenheim Buy → Neutral
Nov-29-21 Downgrade Citigroup Buy → Neutral
Nov-19-21 Initiated BMO Capital Markets Market Perform
Nov-01-21 Upgrade Argus Hold → Buy
Sep-07-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-27-21 Resumed Truist Buy
May-20-21 Downgrade Argus Buy → Hold
Apr-07-21 Resumed RBC Capital Mkts Sector Perform
Nov-10-20 Resumed Bernstein Outperform
Sep-29-20 Initiated Berenberg Hold
Aug-03-20 Upgrade Goldman Neutral → Buy
Jun-12-20 Downgrade Wolfe Research Outperform → Peer Perform
Feb-27-20 Initiated Barclays Overweight
Jan-07-20 Initiated RBC Capital Mkts Sector Perform
Oct-17-19 Resumed BofA/Merrill Neutral
Aug-16-19 Initiated SVB Leerink Outperform
Jul-03-19 Initiated Mizuho Buy
May-28-19 Initiated Goldman Neutral
May-13-19 Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18 Reiterated Citigroup Buy
Oct-09-18 Resumed Guggenheim Buy
Apr-23-18 Upgrade Goldman Neutral → Buy
Apr-17-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18 Upgrade Barclays Equal Weight → Overweight
Mar-12-18 Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18 Reiterated Leerink Partners Mkt Perform
Feb-07-18 Reiterated Morgan Stanley Equal-Weight
Jan-16-18 Upgrade SunTrust Hold → Buy
View All

Merck Co Inc Stock (MRK) Latest News

pulisher
10:00 AM

Merck: An Undervalued Stock In An Expensive Market - Seeking Alpha

10:00 AM
pulisher
09:12 AM

Merck & Co., Inc. (NYSE:MRK) Earns Neutral Rating from Citigroup - MarketBeat

09:12 AM
pulisher
07:29 AM

NorthRock Partners LLC Buys 6,614 Shares of Merck & Co., Inc. $MRK - MarketBeat

07:29 AM
pulisher
07:21 AM

Verdence Capital Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat

07:21 AM
pulisher
07:08 AM

Sequoia Financial Advisors LLC Has $23.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

07:08 AM
pulisher
06:54 AM

Stack Financial Management Inc Sells 4,025 Shares of Merck & Co., Inc. $MRK - MarketBeat

06:54 AM
pulisher
06:21 AM

Johnson Investment Counsel Inc. Sells 11,817 Shares of Merck & Co., Inc. $MRK - MarketBeat

06:21 AM
pulisher
06:10 AM

Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - The Motley Fool

06:10 AM
pulisher
Oct 12, 2025

GW Henssler & Associates Ltd. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Legal Advantage Investments Inc. Acquires 5,040 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

SPC Financial Inc. Sells 4,577 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

OFI Invest Asset Management Has $56.68 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Orca Investment Management LLC Buys Shares of 18,466 Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Cwm LLC Purchases 140,163 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Advocate Group LLC Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Makes New $3.20 Million Investment in Merck & Co., Inc. $MRK - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Merck & Co., Inc. $MRK Shares Acquired by Vanguard Personalized Indexing Management LLC - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Merck & Co. Inc. (MRK): Billionaire D.E. Shaw Is Bullish On This Stock Right Now - MSN

Oct 12, 2025
pulisher
Oct 12, 2025

Merck & Co., Inc. $MRK Shares Purchased by waypoint wealth counsel - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

Merck & Co., Inc. $MRK Shares Acquired by GFS Advisors LLC - MarketBeat

Oct 12, 2025
pulisher
Oct 11, 2025

Merck & Co., Inc. $MRK Shares Sold by Fifth Third Wealth Advisors LLC - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Merck & Co., Inc. $MRK Position Boosted by Drucker Wealth 3.0 LLC - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Eastern Bank Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Merck & Co., Inc. $MRK Shares Sold by Agate Pass Investment Management LLC - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Merck & Co., Inc. (NYSE:MRK) Shares Unloaded Rep. Val T. Hoyle - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Robertson Stephens Wealth Management LLC Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Ramirez Asset Management Inc. Sells 14,666 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

UK Weighs 25% Rise In Drug Prices As Pharma Giants Pause Investments - Benzinga

Oct 10, 2025
pulisher
Oct 10, 2025

JB Capital LLC Grows Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Cascade Investment Group Inc. Acquires New Shares in Merck & Co., Inc. $MRK - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Commerzbank Aktiengesellschaft FI Has $15.70 Million Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Merck & Co., Inc. $MRK Shares Acquired by Vontobel Holding Ltd. - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Merck & Co., Inc. (NYSE:MRK) Given Hold (C-) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Blair William & Co. IL Sells 68,932 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Merck & Co., Inc. $MRK Shares Bought by Mainstay Capital Management LLC ADV - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Live Oak Investment Partners Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Leo Wealth LLC Purchases 15,115 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

US Bancorp DE Sells 115,264 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Insight Inv LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

5,920 Shares in Merck & Co., Inc. $MRK Bought by Allegiance Financial Group Advisory Services LLC - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Armstrong Fleming & Moore Inc Takes $628,000 Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Tectonic Advisors LLC Buys 21,124 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Values Added Financial LLC Takes $248,000 Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Narwhal Capital Management Sells 26,064 Shares of Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Optas LLC Has $817,000 Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Capital Management Associates Inc Purchases New Stake in Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Merck & Co., Inc. $MRK Shares Purchased by Maryland State Retirement & Pension System - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Sax Wealth Advisors LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Merck (NYSE:MRK) Operational Moves Impact Dow Jones Index - Kalkine Media

Oct 09, 2025
pulisher
Oct 08, 2025

MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 08, 2025
pulisher
Oct 08, 2025

Chart Expert Says Merck (MRK) Has More Upside – Here’s Why - Yahoo Finance

Oct 08, 2025

Merck Co Inc Stock (MRK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Merck Co Inc Stock (MRK) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Guindo Chirfi
Chief Marketing Officer
Aug 04 '25
Option Exercise
79.29
36,903
2,926,039
107,409
Smart Dalton E. III
SVP Fin. - Global Controller
May 03 '25
Option Exercise
83.18
2,050
170,519
10,127
Smart Dalton E. III
SVP Fin. - Global Controller
Apr 30 '25
Option Exercise
84.71
464
39,305
8,242
Smart Dalton E. III
SVP Fin. - Global Controller
May 02 '25
Option Exercise
83.26
381
31,722
8,464
Romanelli Joseph
President, Human Health Int?l
May 02 '25
Option Exercise
83.26
2,262
188,334
24,061
Romanelli Joseph
President, Human Health Int?l
Apr 30 '25
Option Exercise
84.71
2,063
174,757
22,816
Larson Betty D
EVP, Chief HR Officer
Apr 30 '25
Option Exercise
84.71
11,350
961,458
11,350
Smart Dalton E. III
SVP Fin. - Global Controller
Apr 25 '25
Option Exercise
58.08
5,000
290,400
12,040
Smart Dalton E. III
SVP Fin. - Global Controller
Apr 25 '25
Sale
82.76
4,262
352,723
7,778
drug_manufacturers_general NVO
$57.80
price up icon 1.53%
$294.69
price up icon 1.50%
drug_manufacturers_general NVS
$129.80
price down icon 0.18%
$118.21
price up icon 0.93%
drug_manufacturers_general PFE
$24.84
price up icon 0.20%
Cap:     |  Volume (24h):